New wound gel could ease pain after belly surgery
NCT ID NCT07353307
First seen Jun 25, 2026 · Last updated Jul 21, 2026 · Updated 3 times
Summary
This phase 3 trial tests a solution called TRD303, applied directly to the surgical wound during closure, to see if it reduces pain after abdominal surgery. About 333 adults having elective abdominal surgery will participate. The study measures pain intensity over 72 hours and checks for side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- TRD303 solution (applied to the surgical wound during closure)
- What this could lead to
- If successful, this could provide a new, effective option for managing pain after abdominal surgery, potentially reducing the need for strong painkillers.
- What could go wrong
- This is a phase 3 trial, but results may not apply to all surgeries or patients. The solution may not work better than existing treatments, and there could be side effects like infection or allergic reaction.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN AFTER ABDOMINAL SURGERY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sichuan Provincial People's Hospital
Sichuan, China
-
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.